Figure 5 | Scientific Reports

Figure 5

From: Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies

Figure 5

Comparison between ELISA and SRID for the estimation of HA content. The X-axis and Y-axis indicate the estimated concentrations by SRID and by ELISA using uAb, respectively. Error bars indicate 95% confidence intervals across duplicated tests. R2 represents coefficient of determination. The HAs subjected to estimations were individual components of quadrivalent influenza vaccine supplied by Green Cross pharma (Yongin, Republic of Korea). (a) The quantification of HAs from A/Singapore/GP1908/2015 IBR-180 (H1N1). (b) The quantification of HAs from A/Hong Kong/4801/2014X-263B (H3N2). (c) The quantification of HAs from B/Phuket/3073/2013 (Yamagata-like). (d) The quantification of HAs from B/Brisbane/60/2008 (Victoria-like).

Back to article page